Optntm1d(EUCOMM)Wtsi
Targeted Allele Detail
|
|
| Symbol: |
Optntm1d(EUCOMM)Wtsi |
| Name: |
optineurin; targeted mutation 1d, Wellcome Trust Sanger Institute |
| MGI ID: |
MGI:6287658 |
| Synonyms: |
Optn null |
| Gene: |
Optn Location: Chr2:5025453-5068862 bp, - strand Genetic Position: Chr2, 3.15 cM
|
| Alliance: |
Optntm1d(EUCOMM)Wtsi page
|
| IMPC: |
Optn gene page |
|
| Germline Transmission: |
Earliest citation of germline transmission:
J:273195
|
| Parent Cell Line: |
JM8.N4 (ES Cell)
|
| Strain of Origin: |
C57BL/6N
|
| Project Collection: |
EUCOMM
|
|
| Allele Type: |
|
Targeted (Null/knockout) |
| Mutation: |
|
Intragenic deletion
|
| |
|
Mutation details: The L1L2_Bact_P cassette was inserted at position 5057375 of Chromosome 2 upstream of the critical exon(s) (Build GRCm39). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site is followed by a neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site. A third loxP site is inserted downstream of the targeted exon(s) at position 5058587. The critical exon(s) is/are thus flanked by loxP sites. A null/knockout allele was created by flp and cre recombinase expression in mice carrying this allele to remove the lacZ sequence, neo selection cassette and the loxP-flanked critical exon(s). Further information on targeting strategies used for this and other IKMC alleles can be found at http://www.informatics.jax.org/mgihome/nomen/IKMC_schematics.shtml
(J:273195)
|
|
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Optn Mutation: |
51 strains or lines available
|
|
| Original: |
J:234166 Ito Y, et al., RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS. Science. 2016 Aug 5;353(6299):603-8 |
| All: |
3 reference(s) |
|